Berkeley Lab and Genentech collaborate to develop new lipid nanoparticles for drug delivery

FHS
July 17, 2023
4:12 pm

Many diseases can be successfully treated in the simple environment of a cell culture dish, but to successfully treat real people, the drug agent has to take a journey through the infinitely more complex environment within our bodies and arrive, intact, inside the affected cells.

The 9th Joint ECTRIMS-ACTRIMS Meeting – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Study results/Conference 11.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Presents

October 12, 2023

Joe Panetta to step down as Biocom California CEO

Joe Panetta, who has led the trade group Biocom California for 25 years, is slated to step down as president and CEO at the end

May 29, 2024

Why the Supreme Court’s overrule of Chevron has major implications for the FDA

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.